Tag Archives: AbbVie

Shire Rings In The New Year With Deal To Buy NPS Pharmaceuticals For $5 Billion

Shire Brushes Its Shoulder Off and cuts deal for NPS.       In October, Shire’s (Nasdaq – SHPG) ill-fated $52 billion deal with AbbVie died due to hysteria over tax inversions. “The deal is the largest casualty yet of … Continue reading

Posted in M&A | Tagged , , , , , , , , , | Leave a comment

Red Pill/Blue Pill Redux. Abbott Board Approves Spin-Off

As we noted here, Abbott Labs is splitting in two.  The board formally approved it and set a December 12 record date for a January 1 dividend date.  Meanwhile, the stock price has not recovered from the body blow delivered … Continue reading

Posted in Opps, Spinoff | Tagged , , , , , , , , , , , , , , , , , , | 3 Comments

Red Pill and Blue Pill . . . Abbott Labs To Split Into Two Separate Public Companies.

It is too late for jokes. Health care company Abbott Laboratories to spin-off AbbVie business. All the way back in October 2011, Abbott Labs announced a plan to split into two companies: Abbott, a medical devices, nutrition, diagnostics and generic … Continue reading

Posted in Spinoff | Tagged , , , , , , , , , , , | 94 Comments